OliX Pharmaceuticals,Inc (226950.KQ)

KRW 18430.0

(-6.07%)

Inventory Summary of OliX Pharmaceuticals,Inc

OliX Pharmaceuticals,Inc's latest annual inventory in 2023 was 468.4 Million KRW , down -28.72% from previous year.
OliX Pharmaceuticals,Inc's latest quarterly inventory in 2024 Q1 was 773 Million KRW , up 65.03% from previous quarter.
OliX Pharmaceuticals,Inc reported annual inventory of 657.17 Million KRW in 2022, up 75.65% from previous year.
OliX Pharmaceuticals,Inc reported annual inventory of 374.12 Million KRW in 2021, up 23.0% from previous year.
OliX Pharmaceuticals,Inc reported quarterly inventory of 793.09 Million KRW for 2024 Q2, up 2.6% from previous quarter.
OliX Pharmaceuticals,Inc reported quarterly inventory of 676.09 Million KRW for 2023 Q1, up 2.88% from previous quarter.

Annual Inventory Chart of OliX Pharmaceuticals,Inc (2023 - 2015)

Historical Annual Inventory of OliX Pharmaceuticals,Inc (2023 - 2015)

Year	Inventory	Inventory Growth
2023	468.4 Million KRW	-28.72%
2022	657.17 Million KRW	75.65%
2021	374.12 Million KRW	23.0%
2020	304.17 Million KRW	-16.85%
2019	365.82 Million KRW	-42.38%
2018	634.83 Million KRW	-13.05%
2017	730.12 Million KRW	0.0%
2016	- KRW	0.0%
2015	- KRW	0.0%

Year	Inventory	Inventory Growth
2024 Q1	773 Million KRW	65.03%
2024 Q2	793.09 Million KRW	2.6%
2023 Q1	676.09 Million KRW	2.88%
2023 FY	468.4 Million KRW	-28.72%
2023 Q3	697.36 Million KRW	2.44%
2023 Q2	680.76 Million KRW	0.69%
2023 Q4	468.4 Million KRW	-32.83%
2022 Q2	408.02 Million KRW	6.78%
2022 FY	657.17 Million KRW	75.65%
2022 Q4	657.17 Million KRW	45.13%
2022 Q3	452.8 Million KRW	10.98%
2022 Q1	382.11 Million KRW	2.13%
2021 Q4	374.12 Million KRW	103.13%
2021 Q1	306.83 Million KRW	0.88%
2021 Q2	337.12 Million KRW	9.87%
2021 Q3	184.18 Million KRW	-45.37%
2021 FY	374.12 Million KRW	23.0%
2020 Q4	304.17 Million KRW	47.02%
2020 FY	304.17 Million KRW	-16.85%
2020 Q1	213.4 Million KRW	-41.66%
2020 Q2	206.88 Million KRW	-3.06%
2020 Q3	206.88 Million KRW	0.0%
2019 Q4	365.82 Million KRW	-8.79%
2019 FY	365.82 Million KRW	-42.38%
2019 Q3	401.05 Million KRW	-9.37%
2019 Q2	442.5 Million KRW	-19.29%
2019 Q1	548.29 Million KRW	-13.63%
2018 Q1	- KRW	0.0%
2018 Q4	634.83 Million KRW	0.0%
2018 FY	634.83 Million KRW	-13.05%
2017 FY	730.12 Million KRW	0.0%
2016 FY	- KRW	0.0%
2015 FY	- KRW	0.0%

Peer Inventory Comparison of OliX Pharmaceuticals,Inc

Name	Inventory	Inventory Difference
HLB Co., Ltd.	11.42 Billion KRW	95.899%
iNtRON Biotechnology, Inc.	1.01 Billion KRW	53.673%
BINEX Co., Ltd.	28.26 Billion KRW	98.343%
Bioneer Corporation	41.35 Billion KRW	98.867%
Anterogen.Co.,Ltd.	1.91 Billion KRW	75.482%
MEDIPOST Co., Ltd.	14.51 Billion KRW	96.773%
CrystalGenomics, Inc.	1.55 Billion USD	69.873%
Helixmith Co., Ltd	914.11 Million KRW	48.758%
Chabiotech Co.,Ltd.	34.11 Billion KRW	98.627%
Medy-Tox Inc.	59.61 Billion KRW	99.214%
Peptron, Inc.	172.18 Million KRW	-172.035%
Amicogen, Inc.	46.83 Billion KRW	99.0%
Genexine, Inc.	3.8 Billion KRW	87.696%
HLB Therapeutics Co.,Ltd.	5.33 Billion KRW	91.221%
LegoChem Biosciences, Inc.	196.83 Million KRW	-137.971%
ALTEOGEN Inc.	1.06 Billion KRW	56.156%
PharmaResearch Co., Ltd.	50.23 Billion KRW	99.068%
SillaJen, Inc.	1.21 Billion KRW	61.372%
JETEMA, Co., Ltd.	12.74 Billion KRW	96.324%
Genomictree Inc.	496.53 Million KRW	5.664%
MedPacto, Inc.	620.00 KRW	-75549780.806%
D&D Pharmatech	3.45 Billion KRW	86.424%
EASY BIO,Inc.	25.93 Billion KRW	98.194%
GI Innovation, Inc.	- KRW	-Infinity%